1. Home
  2. IROQ vs CNTX Comparison

IROQ vs CNTX Comparison

Compare IROQ & CNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IROQ
  • CNTX
  • Stock Information
  • Founded
  • IROQ 1883
  • CNTX 2015
  • Country
  • IROQ United States
  • CNTX United States
  • Employees
  • IROQ N/A
  • CNTX N/A
  • Industry
  • IROQ Savings Institutions
  • CNTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • IROQ Finance
  • CNTX Health Care
  • Exchange
  • IROQ Nasdaq
  • CNTX Nasdaq
  • Market Cap
  • IROQ 82.7M
  • CNTX 75.6M
  • IPO Year
  • IROQ 2011
  • CNTX 2021
  • Fundamental
  • Price
  • IROQ $25.82
  • CNTX $1.14
  • Analyst Decision
  • IROQ
  • CNTX Strong Buy
  • Analyst Count
  • IROQ 0
  • CNTX 7
  • Target Price
  • IROQ N/A
  • CNTX $5.20
  • AVG Volume (30 Days)
  • IROQ 1.8K
  • CNTX 221.2K
  • Earning Date
  • IROQ 11-03-2025
  • CNTX 11-05-2025
  • Dividend Yield
  • IROQ 1.55%
  • CNTX N/A
  • EPS Growth
  • IROQ 139.63
  • CNTX N/A
  • EPS
  • IROQ 1.37
  • CNTX N/A
  • Revenue
  • IROQ $26,459,000.00
  • CNTX N/A
  • Revenue This Year
  • IROQ N/A
  • CNTX N/A
  • Revenue Next Year
  • IROQ N/A
  • CNTX N/A
  • P/E Ratio
  • IROQ $18.85
  • CNTX N/A
  • Revenue Growth
  • IROQ 19.82
  • CNTX N/A
  • 52 Week Low
  • IROQ $19.30
  • CNTX $0.49
  • 52 Week High
  • IROQ $26.21
  • CNTX $2.59
  • Technical
  • Relative Strength Index (RSI)
  • IROQ 56.06
  • CNTX 69.76
  • Support Level
  • IROQ $25.77
  • CNTX $0.98
  • Resistance Level
  • IROQ $25.96
  • CNTX $1.29
  • Average True Range (ATR)
  • IROQ 0.09
  • CNTX 0.09
  • MACD
  • IROQ -0.04
  • CNTX 0.02
  • Stochastic Oscillator
  • IROQ 41.79
  • CNTX 67.05

About IROQ IF Bancorp Inc.

IF Bancorp Inc is a holding company mainly engaged in the business of directing, planning, and coordinating the business activities of Iroquois Federal. The company, in association, takes deposits from the general public and invests those deposits together with funds generated from operations and borrowings in various loans such as multi-family residential and mortgage loans, commercial real estate loans, home equity lines of credit, consumer loans, etc., and offers a variety of deposit accounts and alternative delivery channels. In addition to the traditional banking products and services, the group also offers a full line of property and casualty insurance products, annuities, mutual funds, individual securities, managed accounts, and other financial services.

About CNTX Context Therapeutics Inc.

Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.

Share on Social Networks: